Judge OKs $385 Million Antitrust Settlement Over Suboxone Plot

A federal judge approved a $385 million settlement between a group of direct purchasers and Indivior Inc. over claims the drugmaker abused its monopoly over the Suboxone opioid addiction treatment.

Judge Mitchell S. Goldberg of the US District Court of the Eastern District of Pennsylvania on Tuesday called the $385 million settlement “fair, reasonable, and adequate,” and said it provides plaintiffs who bought the drug with immediate recovery without subjecting them to the rigors of a difficult trial.

Goldberg also approved $120.6 million in attorneys’ fees, or about 32% of the settlement fund amount. Indivior announced the settlement in October. ...